Phase I and translational study of capecitabine, cisplatin, and irinotecan in patients with solid tumors.

被引：0
|
作者：
Verschraegen, CF [1 ]
Lee, FC [1 ]
Rabinowitz, I [1 ]
Mangalik, A [1 ]
Jennings, C [1 ]
Maestas, A [1 ]
Shen, Z [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2114
引用
收藏
页码：155S / 155S
页数：1
相关论文
共 50 条
  • [31] A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.
    Kaiser, C. C.
    Perry, D. J.
    Zimmer, A. S.
    Patterson, J. W.
    Swain, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [34] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
    Deeken, John F.
    Wang, Hongkun
    Smaglo, Brandon George
    Hwang, Jimmy J.
    He, Aiwu Ruth
    Weiner, Louis M.
    Marshall, John
    Giaccone, Giuseppe
    Liu, Stephen V.
    Luecht, Jim
    Urso, Christina
    Spiegel, Jay Y.
    Cheema, Amrita
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Phase I and pharmacokinetic (PK) study of irinotecan (CPT-11) and cisplatin in patients with solid tumors: Preliminary results
    deJonge, MJA
    Sparreboom, A
    Planting, AST
    vanderBurg, MEL
    deBruijn, P
    Brouwer, E
    vanBeurden, V
    vanDuijn, MR
    Jacques, C
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1134 - 1134
  • [36] A phase I study of veliparib (Vel) in combination with oxaliplatin (Ox) and capecitabine (Cap) in advanced solid tumors.
    Turk, Anita Ahmed
    Deming, Dustin A.
    Lubner, Sam Joseph
    Mulkerin, Daniel
    LoConte, Noelle K.
    Tevaarwerk, Amye
    Wisinski, Kari Braun
    Eickhoff, Jens C.
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [37] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [38] A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
    Lam, Elaine T.
    O'Bryant, Cindy L.
    Basche, Michele
    Gustafson, Daniel L.
    Serkova, Natalie
    Baron, Anna
    Holden, Scott N.
    Dancey, Janet
    Eckhardt, S. Gail
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (12) : 3685 - 3694
  • [39] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
  • [40] A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors
    Morgensztern, Daniel
    Baggstrom, Maria Q.
    Pillot, Giancarlo
    Tan, Benjamin
    Fracasso, Paula
    Suresh, Rama
    Wildi, Jonathan
    Govindan, Ramaswamy
    CHEMOTHERAPY, 2009, 55 (06) : 441 - 445
12345